The decision by the Cyprus EU Presidency not to tackle legislative proposals on information on medicines during this half-year is anything but isolated: all the member states have decided by mutual agreement to suspend the Council’s discussions on...
Identification
Bonjour, l'accès à cet article est réservé aux abonnés. Veuillez vous identifier dans le cadre ci-dessous.